Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
H. Zhang
Observed names:
H Zhang,
Huizhen Zhang
Institutions:
Tianjin Medical University Cancer Institute and Hospital,
Henan Polytechnic University
Observed institutions:
Fudan University,
Tianjin Medical University Cancer Institute and Hospital,
Fudan University Shanghai Cancer Center,
Henan Polytechnic University
ORCID:
0009-0003-9396-6612
Observed ORCID:
0009-0003-9396-6612
OpenAlex ID:
A5071898972
Comparison of a Neural Network with High Sensitivity and Specificity to Free/Total Serum PSA for Diagnosing Prostate Cancer in Men with a PSA < 4.0 Ng/Ml
2001
·
T.A. Stamey
, S.D. Barnhill
, et al.
·
CRC Press eBooks
·
4
Identifying Key Epigenetic Modification-Related Genes for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma and Cellular Validation
2025
·
Huizhen Zhang
, Junjie Li
, et al.
·
Current Gene Therapy
·
2
PUK9 Economic Evaluation of Prostate-Specific Antigen Screening for Prostate Cancer in China
2021
·
X. Qin
, C. Gu
, et al.
·
Value in Health
·
1
UP-2.125: Palliative Transurethral Resection of the Prostate (TURP) May Improve Cancer Control in Hormone Sensitive Metastatic Prostate Cancer (PCa)
2009
·
X. Qin
, C. Ma
, et al.
·
Urology
·
1
1246MO Single-cell atlas of circulating immunity identifies shared specific DLBCL signatures for predicting response to R-CHOP and anti-CD19 CAR T therapies
2025
·
S. Zhang
, X. Meng
, et al.
·
Annals of Oncology
A-015 Changes of sST2 and NT-proBNP levels predict early cardiovascular toxicity in breast cancer patients treated with anthracycline-containing chemotherapy
2024
·
C Chen
, R Lu
, et al.
·
Clinical Chemistry
475P Diffusion kurtosis imaging signature in predicting the chemotherapeutic response of colorectal liver metastases: The result of the FDZL-MRinCLM study
2020
·
W. Li
, H. Zhang
, et al.
·
Annals of Oncology
PDF
UP-2.126: Low Dose Metronomic Oral Combined Administration of Etoposide and Cyclophosphamide in Metastatic Hormone Refractory Prostate Cancer After Docetaxol or Mitoxantrone Chemotherapy: A Phase II Study in China
2009
·
Y. Shen
, D. Ye
, et al.
·
Urology
Show more works
View as search
Works count:
8
Citation count:
8
H-index:
2
I10-index:
Year
Topic
Type